Are you Dr. Trevarthen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 S Sherman St
Spokane, WA 99202Phone+1 509-228-1000Fax+1 509-252-9300
Summary
- Dr. David Trevarthen, MD is an oncologist in Spokane, Washington. He is currently licensed to practice medicine in Washington, Kansas, and Wyoming. He is affiliated with Swedish Medical Center and Hays Medical Center.
Education & Training
- Saint Joseph HospitalResidency, Internal Medicine, 1974 - 1977
- University of Wisconsin School of Medicine & Public HealthClass of 1974
Certifications & Licensure
- CO State Medical License 1975 - 2025
- KS State Medical License 2023 - 2025
- WY State Medical License 2022 - 2025
- WA State Medical License 2021 - 2024
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 95 citationsLong‐term safety and efficacy of the PI3K‐ inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 studyMartin Dreyling, Armando Santoro, Luigina Mollica, Sirpa Leppä, George A Follows
American Journal of Hematology. 2020-04-01 - 319 citationsE1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcin...Shanthi Marur, Shuli Li, Anthony J. Cmelak, Maura L. Gillison, Weiqiang Zhao
Journal of Clinical Oncology. 2017-02-10 - 276 citationsPhosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma.Martin Dreyling, Armando Santoro, Luigina Mollica, Sirpa Leppä, George A. Follows
Journal of Clinical Oncology. 2017-10-04
Professional Memberships
- Member
- Member